• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服柚皮苷(一种潜在的镇咳药)在大鼠和犬体内的代谢和排泄研究。

Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs.

机构信息

Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, PR China.

出版信息

Biopharm Drug Dispos. 2012 Apr;33(3):123-34. doi: 10.1002/bdd.1775. Epub 2012 Mar 17.

DOI:10.1002/bdd.1775
PMID:22374702
Abstract

Naringin, a major active flavonone glycoside from a traditional Chinese medicine Huajuhong, has been demonstrated to have activities such as peripheral antitussive, mucoregulator and anti-inflammatory. The purpose of this study was to elucidate the metabolism and mass balance of orally administered naringin in rats and dogs. After oral administration of naringin to rats and dogs at doses of 42 mg/kg and 12.4 mg/kg, respectively, metabolites in excreta were identified using a LC-Q-TOF system. The major metabolites including naringin, total naringenin (including free naringenin and its conjugates) and 4-hydroxyphenylpropionic acid in excreta were quantified by a LC-MS/MS system. Twenty-two metabolites were identified in dogs and 17 metabolites were detected in rats. The observed routes of naringin metabolism were hydroxylation, methylation, acetylation, hydrogenation, deglycosylation, dehydrogenation, glucuronidation, sulfation, glucosylation, ring-fission, oxidation, glycine conjugation and dehydroxylation. On the basis of these identified metabolites, a comprehensive metabolic pathway of naringin was proposed. About 21% of administered naringin was recovered in rat excreta in the form of naringin, total naringenin and 4-hydroxyphenylpropionic acid, and about 60% was recovered in dog excreta. The levels of 4-hydroxyphenylpropionic acid in excreta were higher than those of naringin and total naringenin, and the quantified metabolites were excreted more through feces, rather than urine. Most of these metabolites were excreted within 36 h post dose. The results of metabolism and excretion studies provide an explanation for future pharmacological and toxicological findings and are the groundwork for clinical studies.

摘要

柚皮苷是一种源自中药化橘红的主要活性黄酮糖苷,具有镇咳、黏膜修复和抗炎等作用。本研究旨在阐明柚皮苷在大鼠和犬体内的口服代谢和物质平衡。大鼠和犬分别以 42mg/kg 和 12.4mg/kg 的剂量口服给予柚皮苷后,采用 LC-Q-TOF 系统鉴定排泄物中的代谢物。采用 LC-MS/MS 系统定量测定排泄物中的主要代谢物,包括柚皮苷、总柚皮素(包括游离柚皮素及其缀合物)和 4-羟基苯丙酸。在犬体内鉴定出 22 种代谢物,在大鼠体内检测到 17 种代谢物。观察到的柚皮苷代谢途径包括羟化、甲基化、乙酰化、氢化、去糖基化、脱氢、葡萄糖醛酸化、硫酸化、葡萄糖苷化、环裂、氧化、甘氨酸缀合和去羟化。基于这些鉴定出的代谢物,提出了柚皮苷的综合代谢途径。大鼠排泄物中以柚皮苷、总柚皮素和 4-羟基苯丙酸形式回收的给药柚皮苷约为 21%,犬排泄物中回收的给药柚皮苷约为 60%。排泄物中 4-羟基苯丙酸的水平高于柚皮苷和总柚皮素,且定量代谢物主要通过粪便排泄,而非尿液。这些代谢物大部分在给药后 36 小时内排泄。代谢和排泄研究的结果为未来的药理学和毒理学发现提供了解释,并为临床研究奠定了基础。

相似文献

1
Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs.口服柚皮苷(一种潜在的镇咳药)在大鼠和犬体内的代谢和排泄研究。
Biopharm Drug Dispos. 2012 Apr;33(3):123-34. doi: 10.1002/bdd.1775. Epub 2012 Mar 17.
2
Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对大鼠体内柚皮苷的组织分布研究。
Arzneimittelforschung. 2012 Apr;62(4):181-6. doi: 10.1055/s-0031-1299746. Epub 2012 Jan 23.
3
[UPLC-Q-TOF/MS analysis of naringin and naringenin and its metabolites in rat urine and feces after intragastric administration of alcohol extract of Exocarpium Citri grandis].[柚皮苷和柚皮素及其代谢产物在大鼠灌胃给予柚皮乙醇提取物后尿液和粪便中的超高效液相色谱-四极杆飞行时间质谱分析]
Yao Xue Xue Bao. 2010 Jun;45(6):761-6.
4
Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats.柚皮苷(一种潜在的镇咳药)在大鼠重复口服 184 天后的毒代动力学。
Environ Toxicol Pharmacol. 2011 May;31(3):485-9. doi: 10.1016/j.etap.2011.01.006. Epub 2011 Feb 4.
5
A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma.一种用于大鼠血浆中柚皮苷及其两种代谢物的快速液相色谱/串联质谱定量分析方法。
J Pharm Biomed Anal. 2006 Feb 13;40(2):454-9. doi: 10.1016/j.jpba.2005.07.031. Epub 2006 Jan 10.
6
Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.通过定量和定性代谢物谱分析对放射性标记的muraglitazar在动物和人类中的比较代谢。
Drug Metab Dispos. 2007 Jan;35(1):150-67. doi: 10.1124/dmd.106.012450. Epub 2006 Oct 24.
7
Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.口服直接Xa因子抑制剂利伐沙班在大鼠、犬和人类体内的代谢及排泄情况。
Drug Metab Dispos. 2009 May;37(5):1056-64. doi: 10.1124/dmd.108.025569. Epub 2009 Feb 5.
8
Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.新型抗焦虑候选药物CP-93,393在食蟹猴体内的代谢与排泄:新型嘧啶环裂解代谢物的鉴定
Drug Metab Dispos. 1997 Dec;25(12):1395-406.
9
Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.新型喹诺酮类抗生素曲伐沙星在斯普拉格-道利大鼠和比格犬体内的代谢与排泄。胆管插管对排泄途径的影响。
Drug Metab Dispos. 1996 Nov;24(11):1231-40.
10
Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.新型抗焦虑候选药物CP-93,393在长 Evans 大鼠体内的代谢与排泄。通过液相色谱/串联质谱法区分区域异构体葡糖醛酸苷。
Drug Metab Dispos. 1997 Nov;25(11):1288-97.

引用本文的文献

1
The second life of Citrus bergamia: bioavailability analysis of a new formulation using waste-based microencapsulation as a valuable source of bioactive compounds.香柠檬的二次生命:使用基于废弃物的微胶囊化技术作为生物活性化合物宝贵来源的新制剂的生物利用度分析。
Pharmacol Rep. 2025 Jul 25. doi: 10.1007/s43440-025-00758-x.
2
Naringin and Naringenin: Potential Multi-Target Agents for Alzheimer's Disease.柚皮苷和柚皮素:阿尔茨海默病的潜在多靶标治疗药物。
Curr Med Sci. 2024 Oct;44(5):867-882. doi: 10.1007/s11596-024-2921-z. Epub 2024 Sep 30.
3
The Role of Plant Extracts in Enhancing Nutrition and Health for Dogs and Cats: Safety, Benefits, and Applications.
植物提取物在增强犬猫营养与健康方面的作用:安全性、益处及应用
Vet Sci. 2024 Sep 12;11(9):426. doi: 10.3390/vetsci11090426.
4
Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review.柚皮苷对阿尔茨海默病样病理的基于临床前证据的神经保护潜力:全面综述。
Curr Pharm Biotechnol. 2024;25(9):1112-1123. doi: 10.2174/1389201024666230801095526.
5
Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).对由柚皮苷组成的饲料添加剂进行评估,该添加剂适用于所有动物种类,以更新其授权(HealthTech Bio Actives, S.L.U.(HTBA))。
EFSA J. 2022 Apr 22;20(4):e07267. doi: 10.2903/j.efsa.2022.7267. eCollection 2022 Apr.
6
A Rapid LC-MS/MS Method for Simultaneous Determination of Ten Flavonoid Metabolites of Naringin in Rat Urine and Its Application to an Excretion Study.一种同时测定大鼠尿液中柚皮苷十种黄酮类代谢物的快速液相色谱-串联质谱法及其在排泄研究中的应用
Foods. 2022 Jan 24;11(3):316. doi: 10.3390/foods11030316.
7
Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.重新评估柚皮苷在天然新型骨科生物疗法中的潜力。
Ther Adv Musculoskelet Dis. 2020 Dec 8;12:1759720X20966135. doi: 10.1177/1759720X20966135. eCollection 2020.
8
The Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Pinostrobin in Rats: Ultra-High-Performance Liquid Chromatography Coupled With Linear Trap Quadrupole Orbitrap Mass Spectrometry Studies.松属素在大鼠体内的药代动力学、组织分布、代谢及排泄:超高效液相色谱-线性离子阱四极杆轨道阱质谱联用研究
Front Pharmacol. 2020 Nov 26;11:574638. doi: 10.3389/fphar.2020.574638. eCollection 2020.
9
Flavonoid Naringenin Alleviates Short-Term Osmotic and Salinity Stresses Through Regulating Photosynthetic Machinery and Chloroplastic Antioxidant Metabolism in .类黄酮柚皮素通过调节光合作用机制和叶绿体抗氧化代谢减轻短期渗透胁迫和盐胁迫。
Front Plant Sci. 2020 Jun 3;11:682. doi: 10.3389/fpls.2020.00682. eCollection 2020.
10
Pharmacokinetics and Metabolism of Naringin and Active Metabolite Naringenin in Rats, Dogs, Humans, and the Differences Between Species.柚皮苷及其活性代谢产物柚皮素在大鼠、犬、人类体内的药代动力学与代谢以及种属差异
Front Pharmacol. 2020 Mar 27;11:364. doi: 10.3389/fphar.2020.00364. eCollection 2020.